+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Patient Blood Management Market - Global Forecast 2026-2032- Product Image
Patient Blood Management Market - Global Forecast 2026-2032- Product Image
Sale

Patient Blood Management Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5134244
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Patient Blood Management Market is projected to reach USD 16.44 Billion in 2026. It is expected to continue growing at a CAGR of 6.71%, reaching USD 24.36 Billion by 2032.

Patient Blood Management, or PBM, is an evidence-based, multidisciplinary approach that improves patient outcomes by diagnosing and treating anemia, minimizing blood loss, and optimizing tolerance of anemia before transfusion is considered. The World Health Organization identifies PBM as a patient-safety and health-system efficiency priority, while AABB and major clinical societies continue to reinforce restrictive red blood cell transfusion strategies when clinically appropriate.

For hospitals, surgical centers, blood services, diagnostic developers, and digital health providers, PBM has moved from a clinical protocol to a strategic operating model. Demand is shaped by aging populations, high surgical volumes, chronic disease burden, obstetric and trauma care needs, and persistent pressure on blood supply chains, making transfusion stewardship, perioperative anemia management, cell salvage, hemostasis optimization, and point-of-care coagulation testing core industry themes.

Transformative Shifts in Patient Blood Management

The PBM landscape is shifting from product-centered transfusion support to outcome-centered blood conservation. Health systems are standardizing preoperative anemia screening, iron therapy pathways, antifibrinolytic use, minimally invasive surgery, surgical hemostasis, cell salvage, and evidence-based transfusion thresholds to reduce avoidable allogeneic blood exposure and transfusion-associated risk.

This transition is being accelerated by blood shortages, donor demographic constraints, stronger hemovigilance, antimicrobial and infection-control expectations, and reimbursement pressure linked to quality outcomes. Industry leaders are responding with integrated PBM platforms, rapid diagnostics, clinical decision support, automated inventory management, and education programs that align surgeons, anesthesiologists, intensivists, hematologists, obstetric teams, and transfusion services around safer and more efficient blood utilization.

Cumulative Impact of Artificial Intelligence in PBM

Artificial intelligence is creating cumulative value across PBM by improving identification of patients at risk of anemia, perioperative bleeding, transfusion reactions, and prolonged recovery. AI-enabled models can support earlier anemia workups, predict surgical blood requirements, optimize crossmatch planning, flag inappropriate transfusion orders, and help blood banks forecast demand using historical utilization, seasonality, procedure schedules, emergency activity, and inventory constraints.

The greatest opportunity is not automation alone, but safer decision support embedded into clinical workflows. Hospitals must validate algorithms locally, monitor bias, protect patient data, document model performance, and keep clinicians accountable for final decisions. When governed properly, AI can strengthen transfusion stewardship, reduce wastage, improve stock rotation, and increase responsiveness during shortages, mass-casualty events, or high-acuity care surges.

Key Regional Patient Blood Management Insights

Asia-Pacific is expanding PBM adoption as China, India, Japan, South Korea, and Australia address high procedure volumes, anemia burden, maternal health needs, and uneven access to safe blood components. National hospital modernization programs, surgical capacity expansion, and digital health adoption are reinforcing demand for anemia management, rapid coagulation diagnostics, and transfusion governance. North America remains a mature PBM environment, supported by AABB standards, hospital accreditation expectations, electronic health records, quality improvement programs, and strong uptake of restrictive transfusion guidelines in perioperative, critical care, and medical settings. Latin America shows rising interest in transfusion stewardship, particularly in Brazil and Mexico, although access to diagnostics, standardized hemovigilance, and specialist transfusion medicine resources varies across health systems.

Europe benefits from established national blood systems, EU-level safety and quality alignment, and long-standing PBM programs in countries such as Germany, France, Italy, Spain, and the United Kingdom, where hemovigilance and preoperative anemia management are increasingly embedded in hospital practice. The Middle East is investing in tertiary care, trauma systems, transplant services, oncology, and complex surgery, creating demand for advanced blood management protocols across GCC and neighboring markets. Africa faces the most significant infrastructure and donor-supply constraints, making safe blood access, voluntary donation systems, anemia prevention, maternal care, infectious disease screening, and scalable PBM education essential priorities for resilient healthcare delivery.

Key Group-Level Patient Blood Management Insights

ASEAN countries are advancing PBM through hospital modernization, expanding surgical capacity, and growing demand for safer transfusion practices, with adoption influenced by public-private healthcare investment and variability in national blood services. The GCC is prioritizing PBM as part of broader healthcare transformation, particularly in high-acuity specialties, trauma care, oncology, transplantation, obstetrics, and complex cardiovascular surgery. The European Union provides one of the strongest frameworks for harmonized blood safety standards, hemovigilance, clinical quality improvement, and cross-border regulatory consistency, supporting wider implementation of evidence-based transfusion stewardship.

BRICS markets combine large patient populations with expanding tertiary care capacity, high anemia burden in several settings, and increasing investment in diagnostics and hospital infrastructure, creating strong need for anemia management and transfusion optimization. G7 countries lead in clinical guideline adoption, digital health integration, hospital quality measurement, and high-value care models that support PBM as a patient safety and cost-efficiency strategy. NATO countries add a defense-health dimension, where blood readiness, trauma medicine, emergency preparedness, and resilient supply chains make PBM relevant to both civilian healthcare systems and military medical planning.

Key Country-Level Patient Blood Management Insights

The United States leads in PBM implementation through hospital quality programs, clinical decision support, electronic ordering controls, and AABB-aligned transfusion practices, while Canada emphasizes national blood operator coordination, provincial health-system planning, and evidence-based utilization. Mexico and Brazil are strengthening transfusion services as surgical, oncology, trauma, and obstetric demand expands, with opportunities centered on standardized testing, hemovigilance, and workforce training. The United Kingdom, Germany, France, Italy, and Spain support PBM through mature hospital networks, national blood systems, hemovigilance infrastructure, and growing attention to preoperative anemia management, perioperative blood conservation, and restrictive transfusion thresholds.

Russia has demand tied to trauma, oncology, cardiovascular care, transplant medicine, and regional healthcare modernization. China and India represent major PBM growth environments due to population scale, anemia prevalence, surgical expansion, maternal health needs, and investment in hospital infrastructure and diagnostics. Japan, Australia, and South Korea are advanced PBM adopters with strong clinical governance, high technology penetration, aging population needs, and demand for precision diagnostics, perioperative blood conservation, cell salvage, point-of-care coagulation testing, and digital transfusion stewardship.

Actionable Recommendations for PBM Leaders

Industry leaders should position PBM as an enterprise-wide patient safety strategy rather than a narrow blood utilization initiative. High-impact actions include standardizing anemia screening before elective surgery, integrating iron and hemostasis pathways, expanding cell salvage where appropriate, deploying evidence-based transfusion triggers, and tracking outcomes such as transfusion rates, complications, length of stay, readmissions, blood component wastage, and adherence to clinical protocols.

Commercial teams should prioritize interoperable digital tools, rapid diagnostics, clinical decision support, education partnerships, and implementation support that helps hospitals translate guidelines into measurable practice change. Leaders should also build regional strategies around local blood availability, regulatory requirements, reimbursement models, procurement pathways, hemovigilance maturity, and workforce readiness to ensure PBM programs are clinically credible, operationally scalable, and financially sustainable.

Research Methodology

This executive summary is based on triangulated secondary research from authoritative public sources, including the World Health Organization, AABB, ISBT, national blood services, regulatory agencies, peer-reviewed journals, clinical guidelines, hospital quality frameworks, and international health databases from organizations such as the OECD and World Bank.

The analysis applies evidence screening, source validation, regional mapping, and keyword-focused synthesis to identify strategic PBM trends. Insights were prioritized when supported by clinical consensus, regulatory guidance, hemovigilance evidence, blood safety documentation, or documented health-system practice rather than unverified commercial claims, market sizing, or forecasting assumptions.

Conclusion

Patient Blood Management is becoming a central pillar of safe, efficient, and resilient healthcare delivery. Its value is strongest where hospitals combine early anemia management, blood conservation, hemostasis optimization, evidence-based transfusion decisions, and continuous outcome measurement across surgical, medical, obstetric, trauma, oncology, and critical care pathways.

As blood supply constraints, demographic pressure, quality requirements, and emergency preparedness needs intensify, PBM will remain a priority for providers, policymakers, and industry partners. Organizations that align clinical evidence, digital intelligence, diagnostics, education, and implementation support will be best positioned to lead the next phase of transfusion stewardship and patient-centered blood management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Patient Blood Management Market, by Product Type
7.1. Introduction
7.2. Antifibrinolytics
7.3. Autotransfusion Systems
7.4. Blood Component Separation Systems
7.5. Blood Management Disposables
7.5.1. Cell Washing Kits
7.5.2. Collection Reservoirs
7.5.3. Filtration Devices
7.6. Coagulation Monitoring Systems
7.6.1. Laboratory Analyzers
7.6.2. Point Of Care Devices
7.7. Hemostats And Sealants
7.7.1. Sealant Systems
7.7.2. Topical Hemostats
7.8. Volume Expanders
8. Patient Blood Management Market, by Therapy Type
8.1. Introduction
8.2. Allogeneic Transfusion
8.3. Autologous Transfusion
8.4. Cell Salvage
8.5. Hemostasis Management
8.5.1. Antifibrinolytic Therapy
8.5.2. Topical Hemostats Therapy
8.6. Perioperative Blood Conservation
8.6.1. Intraoperative Techniques
8.6.2. Postoperative Care
8.6.3. Preoperative Optimization
9. Patient Blood Management Market, by Application
9.1. Introduction
9.2. Cardiovascular Surgery
9.2.1. Aortic Surgery
9.2.2. Coronary Artery Bypass Grafting
9.2.3. Valve Replacement Procedures
9.3. Elective Surgery
9.4. Obstetrics
9.5. Oncology Treatments
9.5.1. Chemotherapy
9.5.2. Radiotherapy
9.6. Trauma
10. Patient Blood Management Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospitals
10.5. Specialty Centers
10.5.1. Cancer Treatment Centers
10.5.2. Cardiac Care Centers
10.5.3. Trauma Centers
11. Patient Blood Management Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. Patient Blood Management Market, by Group
12.1. NATO
12.2. G7
12.3. BRICS
12.4. European Union
12.5. ASEAN
12.6. GCC
13. Patient Blood Management Market, by Country
13.1. China
13.2. United States
13.3. Japan
13.4. India
13.5. Germany
13.6. United Kingdom
13.7. Australia
13.8. France
13.9. South Korea
13.10. Italy
13.11. Canada
13.12. Russia
13.13. Brazil
13.14. Mexico
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Baxter International Inc.
15.2. BioMérieux SA
15.3. CSL Limited
15.4. Danaher Corporation
15.5. Fresenius Kabi AG
15.6. Grifols, S.A.
15.7. Haemonetics Corporation
15.8. LivaNova PLC
15.9. Macopharma SA
15.10. Octapharma AG
15.11. Roche Diagnostics International AG
15.12. Terumo Corporation
15.13. ZOLL Medical Corporation
List of Figures
FIGURE 1. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ANTIFIBRINOLYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ANTIFIBRINOLYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ANTIFIBRINOLYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL BLOOD COMPONENT SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL BLOOD COMPONENT SEPARATION SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL BLOOD COMPONENT SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL BLOOD MANAGEMENT DISPOSABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL BLOOD MANAGEMENT DISPOSABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL BLOOD MANAGEMENT DISPOSABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CELL WASHING KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CELL WASHING KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CELL WASHING KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL COLLECTION RESERVOIRS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL COLLECTION RESERVOIRS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL COLLECTION RESERVOIRS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL FILTRATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL FILTRATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL FILTRATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL COAGULATION MONITORING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL COAGULATION MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL COAGULATION MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL LABORATORY ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL LABORATORY ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL LABORATORY ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL POINT OF CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL POINT OF CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL POINT OF CARE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL HEMOSTATS AND SEALANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL HEMOSTATS AND SEALANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL HEMOSTATS AND SEALANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL SEALANT SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SEALANT SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SEALANT SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL TOPICAL HEMOSTATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL TOPICAL HEMOSTATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL TOPICAL HEMOSTATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL VOLUME EXPANDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL VOLUME EXPANDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL VOLUME EXPANDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ALLOGENEIC TRANSFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ALLOGENEIC TRANSFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ALLOGENEIC TRANSFUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL AUTOLOGOUS TRANSFUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL AUTOLOGOUS TRANSFUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL AUTOLOGOUS TRANSFUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CELL SALVAGE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CELL SALVAGE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL CELL SALVAGE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL HEMOSTASIS MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL HEMOSTASIS MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL HEMOSTASIS MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ANTIFIBRINOLYTIC THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ANTIFIBRINOLYTIC THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ANTIFIBRINOLYTIC THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL TOPICAL HEMOSTATS THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL TOPICAL HEMOSTATS THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL TOPICAL HEMOSTATS THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PERIOPERATIVE BLOOD CONSERVATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL PERIOPERATIVE BLOOD CONSERVATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL PERIOPERATIVE BLOOD CONSERVATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL INTRAOPERATIVE TECHNIQUES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL INTRAOPERATIVE TECHNIQUES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL INTRAOPERATIVE TECHNIQUES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL POSTOPERATIVE CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL POSTOPERATIVE CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL POSTOPERATIVE CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PREOPERATIVE OPTIMIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PREOPERATIVE OPTIMIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PREOPERATIVE OPTIMIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CARDIOVASCULAR SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL AORTIC SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL AORTIC SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL AORTIC SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL CORONARY ARTERY BYPASS GRAFTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL VALVE REPLACEMENT PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL VALVE REPLACEMENT PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL VALVE REPLACEMENT PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ELECTIVE SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ELECTIVE SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ELECTIVE SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL OBSTETRICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL OBSTETRICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL OBSTETRICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ONCOLOGY TREATMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ONCOLOGY TREATMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ONCOLOGY TREATMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CHEMOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CHEMOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL CHEMOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL RADIOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL RADIOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL TRAUMA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL TRAUMA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL TRAUMA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL SPECIALTY CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL SPECIALTY CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL SPECIALTY CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL CANCER TREATMENT CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL CANCER TREATMENT CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL CANCER TREATMENT CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL CARDIAC CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL CARDIAC CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL CARDIAC CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL TRAUMA CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL TRAUMA CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL TRAUMA CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 144. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 146. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 147. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 148. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 149. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 150. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 151. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 152. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 153. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 154. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 155. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 156. EUROPE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 169. NORTH AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 180. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 181. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. LATIN AMERICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 183. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 184. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 185. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 186. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 187. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 188. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 189. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 190. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 191. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 192. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 193. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 194. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 195. AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 206. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 207. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 208. MIDDLE EAST PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 209. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 210. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 211. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 212. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 213. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 214. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 215. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 216. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 217. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 218. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 219. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 220. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 221. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. NATO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 223. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 224. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 226. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 227. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 228. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 229. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 230. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 231. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 232. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 233. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 234. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. G7 PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 236. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 238. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 239. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 240. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 241. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 242. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 243. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 244. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 245. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 246. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 247. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 248. BRICS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 262. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 263. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 264. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 265. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 266. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 267. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 268. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 269. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 270. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 271. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 272. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 273. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. ASEAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 275. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 276. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 277. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 278. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 279. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 280. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 281. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 282. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 283. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 285. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 286. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 287. GCC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 288. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 289. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 290. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 291. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 292. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 293. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 294. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 295. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 296. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 297. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 299. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 300. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 305. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 306. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 307. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 308. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 309. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 310. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 311. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 312. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 313. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 314. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 315. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 316. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 317. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 318. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 319. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 320. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 321. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 322. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 323. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 324. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2017-2032 (USD MILLION)
TABLE 325. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ONCOLOGY TREATMENTS, 2017-2032 (USD MILLION)
TABLE 326. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 327. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SPECIALTY CENTERS, 2017-2032 (USD MILLION)
TABLE 328. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 329. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 330. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD MANAGEMENT DISPOSABLES, 2017-2032 (USD MILLION)
TABLE 331. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COAGULATION MONITORING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 332. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTATS AND SEALANTS, 2017-2032 (USD MILLION)
TABLE 333. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY THERAPY TYPE, 2017-2032 (USD MILLION)
TABLE 334. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMOSTASIS MANAGEMENT, 2017-2032 (USD MILLION)
TABLE 335. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PERIOPERATIVE BLOOD CONSERVATION, 2017-2032 (USD MILLION)
TABLE 336. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APPLICATION, 2

Companies Mentioned

  • Baxter International Inc.
  • BioMérieux SA
  • CSL Limited
  • Danaher Corporation
  • Fresenius Kabi AG
  • Grifols, S.A.
  • Haemonetics Corporation
  • LivaNova PLC
  • Macopharma SA
  • Octapharma AG
  • Roche Diagnostics International AG
  • Terumo Corporation
  • ZOLL Medical Corporation

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.44 Billion
Forecasted Market Value ( USD ) by 2032 $ 24.36 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Patient Blood Management - Global Strategic Business Report - Product Image

Patient Blood Management - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Patient Blood Management - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Patient Blood Management - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 150 Pages
  • Global
From
Patient Blood Management Market Report 2026 - Product Image

Patient Blood Management Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Patient Blood Management Market Insights, Competitive Landscape, and Market Forecast - 2033 - Product Image

Patient Blood Management Market Insights, Competitive Landscape, and Market Forecast - 2033

  • Report
  • 200 Pages
  • Global
From
Thromboelastography Coagulation Analyzer Market - Global Forecast 2026-2032 - Product Image

Thromboelastography Coagulation Analyzer Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From

About the Market

Patient Blood Management (PBM) is a medical strategy that focuses on optimizing the care of patients who require blood transfusions. It is a multidisciplinary approach that involves the use of evidence-based practices to reduce the need for allogeneic blood transfusions, while ensuring the safety of the patient. PBM includes strategies such as preoperative anemia management, intraoperative blood salvage, and the use of alternative blood products. It also involves the use of blood conservation techniques such as cell salvage, erythropoietin, and iron supplementation. PBM is an important part of blood banking, as it helps to reduce the demand for allogeneic blood transfusions and improve patient outcomes. It is also beneficial to blood banks, as it helps to reduce the cost of blood products and improve the efficiency of the blood supply. Some companies in the PBM market include Fresenius Kabi, Haemonetics Corporation, Terumo BCT, and Grifols. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.